Medicine and Dentistry
Visual Acuity
100%
Endophthalmitis
59%
Macular Edema
45%
Cataract Surgery
44%
Central Retinal Vein Occlusion
40%
Pars Plana Vitrectomy
32%
Vasculotropin
32%
Diabetic Macular Edema
31%
Optical Coherence Tomography
31%
Retina Vein Occlusion
31%
Retinal Detachment
30%
Bevacizumab
30%
Intravitreal Administration
28%
Hemiretinal Vein Occlusion
27%
Ophthalmology
27%
Diabetic Retinopathy
26%
Intraocular Pressure
25%
Proliferative Diabetic Retinopathy
24%
Laser Coagulation
23%
Randomized Clinical Trial
21%
Best Corrected Visual Acuity
20%
Age Related Macular Degeneration
18%
Clinical Trial
18%
Triamcinolone Acetonide
17%
Branch Retinal Vein Occlusion
16%
Glaucoma
16%
Cataract
16%
Ranibizumab
15%
Triamcinolone
14%
Agents Acting on the Eye
14%
Implant
14%
Visual Impairment
13%
Aflibercept
13%
Silicone Oil
12%
Vitrectomy
11%
Drug Therapy
11%
Clinical Feature
11%
Intraocular Lens
11%
Fluorescein
10%
Vitreoretinal Surgery
10%
Phacoemulsification
10%
Neoplasm
9%
Surgeon
9%
Trabeculectomy
9%
Vitreous
8%
Retinoblastoma
8%
Medical Record
8%
Spectral Domain Optical Coherence Tomography
8%
Vitreous Hemorrhage
7%
Vision
7%
Keyphrases
Visual Acuity
85%
Retinal Vein Occlusion
73%
Endophthalmitis
51%
Macular Edema
42%
Cataract Surgery
41%
Pars Plana Vitrectomy
35%
Diabetic Macular Edema
34%
Age-related Macular Degeneration
30%
Intravitreal Injection
28%
Intravitreal Bevacizumab
27%
Visual Acuity Outcome
25%
Bevacizumab
25%
Optical Coherence Tomography
24%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
21%
Best-corrected Visual Acuity
20%
Proliferative Diabetic Retinopathy
18%
Corticosteroids
18%
Aflibercept
18%
Intraocular Pressure
18%
Visual Outcome
16%
Triamcinolone Acetonide
16%
Central Subfield Thickness
16%
Branch Retinal Vein Occlusion
15%
Recurrent Retinal Detachment
15%
Anti-vascular Endothelial Growth Factor Therapy
15%
Retina
14%
Intravitreal
14%
Randomized Clinical Trial
14%
Retinal Detachment
13%
Diabetic Retinopathy
13%
American Academy of Ophthalmology
13%
Intravitreal Ranibizumab
12%
United States
12%
Vitreoretinal Surgery
12%
Early Treatment Diabetic Retinopathy Study
12%
Clinical Features
12%
Retinal Thickness
12%
Central Vein Occlusion
11%
Rhegmatogenous Retinal Detachment
11%
Confidence Interval
10%
Cataract
10%
Retinoblastoma
10%
Ranibizumab
9%
Vision Loss
9%
Visual Impairment
9%
Avastin
9%
Glaucoma
9%
Acute Onset
9%
Ophthalmology
8%
Intravitreal Triamcinolone Acetonide Injection
8%